2004 Annual Report

Financial Summary

Fiscal Years 2004 and 2003

Consolidated Balance Sheets

Assets
(in thousands of dollars)		 June 30, 2004 June 30, 2003
Cash and cash equivalents $       6,681 $       9,994
Grants and contracts receivable 11,924  7,013
Other receivables 27,327 11,561
Investments, at market 111,273 89,868
Trustee-held funds 14,347 61,514
Land, buildings and equipment,
  net of accumulated depreciation
  of $154,714 and $136,724		 317,201 275,392
Deferred financing costs, net 13,343 13,635
Total assets $ 502,096 $ 468,977
 
Liabilities and net assets
(in thousands of dollars)		 June 30, 2004 June 30, 2003
Accounts payable and accrued liabilities $    37,738 $    49,587
Accrued payroll and related costs 15,218 13,492
Long-term debt and payable to government agencies 306,539 306,655
Deferred revenue 7,351 5,708
Total liabilities 366,846 375,442
 
Unrestricted net assets 100,982 75,235
Temporarily restricted net assets 22,728 11,536
Permanently restricted net assets 11,540 6,764
Total net assets 135,250 93,535
 
Total liabilities and net assets $ 502,096 $ 468,977

 

 

The generosity of private contributors helped support:

  • Seed money for new developments in cancer research, including early detection, prevention, diagnosis and treatment
  • Funding for studies of leukemia, lymphoma, breast cancer, ovarian cancer, prostate cancer, AIDS, and other related diseases
  • Housing, food and transportation for patients and family members through the Family Assistance Fund
  • Postdoctoral and oncology fellowships for new scientists
  • Research equipment
  • Up-to-date cancer information for the public through the Cancer Information Service (1-800-4-CANCER)

Fiscal year 2004 contributions received (in thousands of dollars)

Consolidated Statements of Activity

Revenues and other support
(in thousands of dollars)		 June 30, 2004 June 30, 2003
Research grants and contracts $ 217,297 $ 209,310
Contributions, net of cost of special events of $938 and $740 29,789 20,097
Investment income and realized gains and losses 15,339 1,043
Other income 24,054 18,512
Total revenues $ 286,479 $  48,962
 
 
Expenses
(in thousands of dollars)		 June 30, 2004 June 30, 2003
Program services—research $ 198,338 $ 187,073
Management and general 64,385 54,684
Fund raising 4,245 3,500
Total expenses $ 266,968 $ 245,257
 
Change in net assets from operations 19,511 3,705
Changes in net assets from financing activities and extraordinary gain 22,204 (17,404)
Total increase (decrease) in net assets 41,715 (13,699 )
Net assets balance at beginning of year 93,535 107,234
Net assets balance at end of year $135,250 $ 93,535

 

Major direct sources of support (in millions of dollars)

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.